Schonfeld Strategic Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-193,900
| Closed | -$35.6M | – | 2591 |
|
|
2021
Q2 | $35.6M | Buy |
193,900
+86,093
| +80% | +$15.8M | 0.38% | 41 |
|
|
2021
Q1 | $16.5M | Buy |
107,807
+23,892
| +28% | +$3.65M | 0.2% | 110 |
|
|
2020
Q4 | $13.1M | Buy |
83,915
+69,548
| +484% | +$10.9M | 0.18% | 148 |
|
|
2020
Q3 | $1.64M | Sell |
14,367
-10,174
| -41% | -$1.16M | 0.03% | 529 |
|
|
2020
Q2 | $2.75M | Buy |
24,541
+9,269
| +61% | +$1.04M | 0.07% | 315 |
|
|
2020
Q1 | $1.37M | Buy |
15,272
+5,265
| +53% | +$473K | 0.09% | 280 |
|
|
2019
Q4 | $1.08M | Sell |
10,007
-44,631
| -82% | -$4.83M | 0.03% | 489 |
|
|
2019
Q3 | $5.35M | Buy |
54,638
+45,960
| +530% | +$4.5M | 0.16% | 165 |
|
|
2019
Q2 | $1.14M | Buy |
8,678
+6,703
| +339% | +$877K | 0.04% | 416 |
|
|
2019
Q1 | $267K | Sell |
1,975
-19,299
| -91% | -$2.61M | 0.01% | 865 |
|
|
2018
Q4 | $2.07M | Sell |
21,274
-19,926
| -48% | -$1.94M | 0.08% | 318 |
|
|
2018
Q3 | $5.73M | Buy |
41,200
+6,200
| +18% | +$862K | 0.25% | 116 |
|
|
2018
Q2 | $4.35M | Sell |
35,000
-3,451
| -9% | -$428K | 0.24% | 149 |
|
|
2018
Q1 | $4.29M | Buy |
38,451
+5,906
| +18% | +$658K | 0.32% | 86 |
|
|
2017
Q4 | $3.89M | Buy |
32,545
+7,108
| +28% | +$850K | 0.32% | 90 |
|
|
2017
Q3 | $3.57M | Buy |
25,437
+10,897
| +75% | +$1.53M | 0.33% | 101 |
|
|
2017
Q2 | $1.77M | Sell |
14,540
-2,495
| -15% | -$304K | 0.18% | 171 |
|
|
2017
Q1 | $2.07M | Sell |
17,035
-19,119
| -53% | -$2.32M | 0.21% | 137 |
|
|
2016
Q4 | $4.42M | Buy |
+36,154
| New | +$4.42M | 0.57% | 40 |
|
|
2016
Q3 | – | Sell |
-46,768
| Closed | -$5.46M | – | 592 |
|
|
2016
Q2 | $5.46M | Buy |
46,768
+43,768
| +1,459% | +$5.11M | 1.22% | 10 |
|
|
2016
Q1 | $418K | Buy |
+3,000
| New | +$418K | 0.17% | 152 |
|